Phase 1 study of LX2761 in diabetes patients

Trial Profile

Phase 1 study of LX2761 in diabetes patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs LX 2761 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Aug 2017 According to a Lexicon Pharmaceuticals media release, data from this study is expected in second half of 2017.
    • 02 May 2017 According to a Lexicon Pharmaceuticals media release, the Company anticipates the release of data this year from these studies in healthy subjects and patients with T2DM.
    • 11 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top